Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

P. van der Leest; B. Hiddinga; A. Miedema; Aguirre M. L. Azpurua; N. Rifaela; A. ter Elst; W. Timens; H. J. M. Groen; L. C. van Kempen; T. J. N. Hiltermann

doi:10.1002/1878-0261.13139

Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

P. van der Leest, B. Hiddinga, A. Miedema, Aguirre M. L. Azpurua, N. Rifaela, A. ter Elst, W. Timens, H. J. M. Groen, L. C. van Kempen, T. J. N. Hiltermann

Research output: Contribution to journal › Erratum

72 Downloads (Pure)

Abstract

The following error appeared in Section 3.5 in Ref. [1]. Instead of ‘Progressive disease-L1 expression data were available for 87 patients’, the text should read ‘PD-L1 expression data were available for 87 patients’. We apologize for this error.

Original language	English
Pages (from-to)	310-310
Number of pages	1
Journal	Molecular oncology
Volume	16
Issue number	1
DOIs	https://doi.org/10.1002/1878-0261.13139
Publication status	Published - Jan-2022

Access to Document

10.1002/1878-0261.13139Licence: CC BY

Erratum to Circulating tumor DNA as a biomarker for monitoring early treatment responses ofFinal publisher's version, 72.5 KBLicence: CC BY

Handle.net

Persistent link

1 Article

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
van der Leest, P., Hiddinga, B., Miedema, A., Aguirre Azpurua, M. L., Rifaela, N., Ter Elst, A., Timens, W., Groen, H. J. M., van Kempen, L. C., Hiltermann, T. J. N. & Schuuring, E., Nov-2021, In: Molecular oncology. 15, 11, p. 2910-2922 13 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
24 Citations (Scopus)

218 Downloads (Pure)

Cite this

van der Leest, P., Hiddinga, B., Miedema, A., Azpurua, A. M. L., Rifaela, N., ter Elst, A., Timens, W., Groen, H. J. M., van Kempen, L. C., & Hiltermann, T. J. N. (2022). Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors. Molecular oncology, 16(1), 310-310. https://doi.org/10.1002/1878-0261.13139

@article{f2fa03f3ca7f4b188c5b2f2619464ad7,

title = "Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.",

abstract = "The following error appeared in Section 3.5 in Ref. [1]. Instead of {\textquoteleft}Progressive disease-L1 expression data were available for 87 patients{\textquoteright}, the text should read {\textquoteleft}PD-L1 expression data were available for 87 patients{\textquoteright}. We apologize for this error.",

author = "{van der Leest}, P. and B. Hiddinga and A. Miedema and Azpurua, {Aguirre M. L.} and N. Rifaela and {ter Elst}, A. and W. Timens and Groen, {H. J. M.} and {van Kempen}, {L. C.} and Hiltermann, {T. J. N.}",

year = "2022",

month = jan,

doi = "10.1002/1878-0261.13139",

language = "English",

volume = "16",

pages = "310--310",

journal = "Molecular oncology",

issn = "1574-7891",

publisher = "Wiley",

number = "1",

}

van der Leest, P , Hiddinga, B, Miedema, A, Azpurua, AML, Rifaela, N, ter Elst, A , Timens, W , Groen, HJM , van Kempen, LC & Hiltermann, TJN 2022, 'Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.', Molecular oncology, vol. 16, no. 1, pp. 310-310. https://doi.org/10.1002/1878-0261.13139

TY - JOUR

T1 - Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

AU - van der Leest, P.

AU - Hiddinga, B.

AU - Miedema, A.

AU - Azpurua, Aguirre M. L.

AU - Rifaela, N.

AU - ter Elst, A.

AU - Timens, W.

AU - Groen, H. J. M.

AU - van Kempen, L. C.

AU - Hiltermann, T. J. N.

PY - 2022/1

Y1 - 2022/1

N2 - The following error appeared in Section 3.5 in Ref. [1]. Instead of ‘Progressive disease-L1 expression data were available for 87 patients’, the text should read ‘PD-L1 expression data were available for 87 patients’. We apologize for this error.

AB - The following error appeared in Section 3.5 in Ref. [1]. Instead of ‘Progressive disease-L1 expression data were available for 87 patients’, the text should read ‘PD-L1 expression data were available for 87 patients’. We apologize for this error.

U2 - 10.1002/1878-0261.13139

DO - 10.1002/1878-0261.13139

M3 - Erratum

SN - 1574-7891

VL - 16

SP - 310

EP - 310

JO - Molecular oncology

JF - Molecular oncology

IS - 1

ER -

Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

Abstract

Access to Document

Handle.net

Fingerprint

Research output

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors

Cite this